BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 27095642)

  • 1. The ABCs of Immunosuppression: A Primer for Primary Care Physicians.
    Malat G; Culkin C
    Med Clin North Am; 2016 May; 100(3):505-18. PubMed ID: 27095642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
    Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB
    Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation.
    Woodle ES; Bruce DS; Josephson M; Newell KA; Piper JB; Millis JM; Cronin D; Whitman G; Ruebe M; Thistlethwaite JR
    Clin Transplant; 1996 Aug; 10(4):323-32. PubMed ID: 8884103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppression in organ transplantation.
    Jordan SC; Rosenthal P; Makowka L
    Semin Pediatr Surg; 1993 Nov; 2(4):206-7. PubMed ID: 8062042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current and evolving immunosuppressive regimens in kidney transplantation.
    Gaston RS
    Am J Kidney Dis; 2006 Apr; 47(4 Suppl 2):S3-21. PubMed ID: 16567239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nutritional and metabolic issues in solid organ transplantation: targets for future research.
    Ward HJ
    J Ren Nutr; 2009 Jan; 19(1):111-22. PubMed ID: 19121784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of Immunosuppression in Liver Transplantation.
    Dhanasekaran R
    Clin Liver Dis; 2017 May; 21(2):337-353. PubMed ID: 28364817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
    Uslu A; Nart A; Taşli FA; Postaci H; Aykas A; Doğan M; Sahin T
    Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunopharmacologic therapy in renal transplantation.
    Shoker AS
    Pharmacotherapy; 1996; 16(4):562-75. PubMed ID: 8840362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunosuppression in organ transplantation. New substances and therapeutic approaches].
    Wonigeit K
    Internist (Berl); 1996 Mar; 37(3):229-39. PubMed ID: 8919940
    [No Abstract]   [Full Text] [Related]  

  • 11. The Evolution of Lung Transplant Immunosuppression.
    Ivulich S; Westall G; Dooley M; Snell G
    Drugs; 2018 Jul; 78(10):965-982. PubMed ID: 29915895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hot-topic debate on tolerance: immunosuppression withdrawal.
    Sánchez-Fueyo A
    Liver Transpl; 2011 Nov; 17 Suppl 3():S69-73. PubMed ID: 21850680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic renal allograft damage: existing challenges.
    Arias M; Serón D; Moreso F; Bestard O; Praga M
    Transplantation; 2011 May; 91(9 Suppl):S4-25. PubMed ID: 21519213
    [No Abstract]   [Full Text] [Related]  

  • 14. Maintenance immunosuppressive therapy in adult renal transplantation: a single center analysis.
    Säemann MD; Sunder-Plassmann G
    Transpl Immunol; 2008 Nov; 20(1-2):14-20. PubMed ID: 18804533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Present state of immunosuppressive therapy in liver transplant recipients.
    Wiesner RH; Fung JJ
    Liver Transpl; 2011 Nov; 17 Suppl 3():S1-9. PubMed ID: 21850697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppressive Therapy in Transplantation.
    Allison TL
    Nurs Clin North Am; 2016 Mar; 51(1):107-20. PubMed ID: 26897428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal dose and type of immunosuppression in a national cohort of Australian liver, heart, and lung transplant recipients, 1984-2006.
    Na R; Laaksonen MA; Grulich AE; Webster AC; Meagher NS; McCaughan GW; Keogh AM; Vajdic CM
    Clin Transplant; 2015 Nov; 29(11):978-90. PubMed ID: 26278925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of immunosuppression and acute rejection on recurrence of hepatitis C: results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database.
    Charlton M; Seaberg E
    Liver Transpl Surg; 1999 Jul; 5(4 Suppl 1):S107-14. PubMed ID: 10431024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunosuppression in the kidney transplant. Old drugs and new acquisitions].
    Rodríguez Ferrero M; Valderrábano F
    Rev Clin Esp; 1997 Oct; 197(10):703-12. PubMed ID: 9424669
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of early cyclosporine levels on kidney allograft rejection.
    Johnson EM; Canafax DM; Gillingham KJ; Humar A; Pandian K; Kerr SR; Najarian JS; Matas AJ
    Clin Transplant; 1997 Dec; 11(6):552-7. PubMed ID: 9408683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.